Virtu Financial’s TRACON Pharmaceuticals TCON Stock Holding History
Bought
Maintained
Sold
Other funds holding TCON
OM
Virtu Financial's TCON Position: Q3 2023 in Review
Virtu Financial sold out of TRACON Pharmaceuticals (TCON) in Q3 2023, closing a stake of 1,418 shares — an estimated $8K sold.
Virtu Financial first reported a position in TCON in Q3 2017 and held it in 12 quarters. The position peaked at $316K in Q3 2020. 21 funds tracked by Wall St. Rank hold TCON as of Q3 2023.
- Virtu Financial reported no remaining TRACON Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
- Virtu Financial sold 1,418 TRACON Pharmaceuticals shares in Q3 2023, an estimated $8K.
- Virtu Financial first reported a position in TRACON Pharmaceuticals in Q3 2017 and held it in 12 quarters.
- Virtu Financial's TRACON Pharmaceuticals position peaked at $316K in Q3 2020.
- 21 funds tracked by Wall St. Rank held TRACON Pharmaceuticals as of Q3 2023.
Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.